RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
HLB Life Science Co Stock

HLB Life Science Co Dividend 2024

HLB Life Science Co Dividend

0 KRW

HLB Life Science Co Dividend yield

Ticker

067630.KQ

ISIN

KR7067630004

How much dividend does HLB Life Science Co 2024 pay?

According to the latest status from August 2024, HLB Life Science Co paid a total of 0 KRW per share in dividends within the last 12 months. With the current HLB Life Science Co price of 10,600 KRW, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical HLB Life Science Co Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the HLB Life Science Co Dividend Safe?

HLB Life Science Co has been increasing the dividend for 0 years.

Over the past 10 years, HLB Life Science Co has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding HLB Life Science Co's Dividend Distributions

HLB Life Science Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining HLB Life Science Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

HLB Life Science Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in HLB Life Science Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

HLB Life Science Co Aktienanalyse

What does HLB Life Science Co do?

HLB Life Science Co., Ltd. is a leading company in the research, development, and production of biotechnological and pharmaceutical products. The company was founded in 2015 in Seoul, South Korea. Due to the founders' extensive experience in the field of life science and biotechnology, HLB Life Science has quickly established itself as a key player in the industry. HLB Life Science's business model is based on the development and production of innovative biotechnological and pharmaceutical products, as well as collaboration with other companies and research institutions. The aim is to improve people's quality of life by providing effective and safe medications and therapies. The company is divided into various divisions. The Biopharmaceuticals division includes the development and production of biotechnological products such as antibodies, proteins, vaccines, and diagnostics. The Pharmaceuticals division develops and produces advanced drugs in the field of oncology, immunology, and neurology. The Clinical Research Services division offers contract research services in the field of clinical studies to test the effectiveness and safety of drugs. In addition, HLB Life Science Co., Ltd. is also active in the Nutra-Pharmaceuticals division, specializing in the development and production of dietary supplements. HLB Life Science offers various products tailored to the needs of patients. In the field of Biopharmaceuticals, for example, the company produces antibodies and proteins for the treatment of cancer, inflammatory diseases, and infections. Another innovative product is a fully humanized antibody against the hepatitis B virus, which is one of the most common liver diseases. In the Pharmaceuticals field, HLB Life Science offers innovative drugs for the treatment of cancer, autoimmune diseases, and neurological disorders. In the Nutra-Pharmaceuticals field, the company offers dietary supplements based on natural ingredients that can strengthen the immune system. HLB Life Science Co., Ltd. is known in the industry for its innovative strength and excellent research results. The company places great emphasis on continuous research and development to develop innovative products and continuously improve existing products. Due to their outstanding products and services, HLB Life Science has already exported to various countries worldwide and has thus played a significant role in the global market. Looking to the future, HLB Life Science Co., Ltd. continues to focus on innovative research and development, as well as close collaboration with universities and research institutions. The company aims to improve people's health and well-being through effective and safe medications and therapies. HLB Life Science Co is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about HLB Life Science Co stock

How much dividend does HLB Life Science Co pay?

Over the past 12 months, HLB Life Science Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, HLB Life Science Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of HLB Life Science Co?

The current dividend yield of HLB Life Science Co is .

When does HLB Life Science Co pay dividends?

HLB Life Science Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of HLB Life Science Co?

HLB Life Science Co paid dividends every year for the past 0 years.

What is the dividend of HLB Life Science Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is HLB Life Science Co located?

HLB Life Science Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von HLB Life Science Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of HLB Life Science Co from 8/7/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 8/7/2024.

When did HLB Life Science Co pay the last dividend?

The last dividend was paid out on 8/7/2024.

What was the dividend of HLB Life Science Co in the year 2023?

In the year 2023, HLB Life Science Co distributed 0 KRW as dividends.

In which currency does HLB Life Science Co pay out the dividend?

The dividends of HLB Life Science Co are distributed in KRW.

Andere Kennzahlen von HLB Life Science Co

Our stock analysis for HLB Life Science Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HLB Life Science Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.